Conduct study P221
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Bioqual, Inc. UEI CK9LGQ7EBNN8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,999,460
Award facts
- Contract value 100% obligated
- $1,999,460.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,999,460 |
About this award
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit organization, to conduct a study called "CONDUCT STUDY P221." The contract has a ceiling value of $1,999,460.00 and is a delivery order under the Simian Vaccine Evaluation Units (SVEU) indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle held by NIAID. The contract has an ultimate completion date of August 31, 2025 and was awarded on September 1, 2023. This award does not have a set-aside designation.
Bioqual, Inc. is an experienced research services provider that supports biomedical research programs, including serving as a prime contractor for NIAID to conduct animal studies, provide laboratory analysis, and house and care for research animals. This specific award is likely related to NIAID's infectious disease research efforts, as Bioqual has supported NIAID's work in areas such as HIV cure research, immune system studies, and testing of radiation recovery compounds.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Bioqual, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $1,999,460 on 75N93023F00001.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under 75N93020D00006, an indefinite delivery contract, on Simian Vaccine Evaluation Units.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award